JP4786843B2 - インターロイキン−６から誘導されるレトロ−インベルソペプチド - Google Patents

インターロイキン−６から誘導されるレトロ−インベルソペプチド Download PDF

Info

Publication number
JP4786843B2
JP4786843B2 JP2001503890A JP2001503890A JP4786843B2 JP 4786843 B2 JP4786843 B2 JP 4786843B2 JP 2001503890 A JP2001503890 A JP 2001503890A JP 2001503890 A JP2001503890 A JP 2001503890A JP 4786843 B2 JP4786843 B2 JP 4786843B2
Authority
JP
Japan
Prior art keywords
peptide
cells
peptides
retro
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001503890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003502343A (ja
Inventor
イー． ライト，デイビッド
パークス，ディー．エリオット
Original Assignee
マイアロス コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイアロス コーポレイション filed Critical マイアロス コーポレイション
Publication of JP2003502343A publication Critical patent/JP2003502343A/ja
Application granted granted Critical
Publication of JP4786843B2 publication Critical patent/JP4786843B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2001503890A 1999-06-16 2000-06-16 インターロイキン−６から誘導されるレトロ−インベルソペプチド Expired - Fee Related JP4786843B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13968799P 1999-06-16 1999-06-16
US60/139,687 1999-06-16
PCT/US2000/040227 WO2000077033A1 (fr) 1999-06-16 2000-06-16 Peptides rétro-inverses dérivés de l'interleukine 6

Publications (2)

Publication Number Publication Date
JP2003502343A JP2003502343A (ja) 2003-01-21
JP4786843B2 true JP4786843B2 (ja) 2011-10-05

Family

ID=22487847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001503890A Expired - Fee Related JP4786843B2 (ja) 1999-06-16 2000-06-16 インターロイキン−６から誘導されるレトロ−インベルソペプチド

Country Status (6)

Country Link
EP (1) EP1183267A4 (fr)
JP (1) JP4786843B2 (fr)
AU (1) AU6540500A (fr)
CA (1) CA2376479A1 (fr)
IL (3) IL147094A0 (fr)
WO (1) WO2000077033A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032895A1 (fr) * 1996-03-05 1997-09-12 Regents Of The University Of California Methodes de soulagement de la douleur nevropathique a l'aide de peptides derives de prosaposine
WO1998039357A1 (fr) * 1997-03-05 1998-09-11 The Regents Of The University Of California Procedes pour soulager les douleurs neuropathiques
WO1999012967A1 (fr) * 1997-09-09 1999-03-18 Myelos Neurosciences Corporation Peptides analgesiques et neurotrophiques retro-inverses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032895A1 (fr) * 1996-03-05 1997-09-12 Regents Of The University Of California Methodes de soulagement de la douleur nevropathique a l'aide de peptides derives de prosaposine
WO1998039357A1 (fr) * 1997-03-05 1998-09-11 The Regents Of The University Of California Procedes pour soulager les douleurs neuropathiques
WO1999012967A1 (fr) * 1997-09-09 1999-03-18 Myelos Neurosciences Corporation Peptides analgesiques et neurotrophiques retro-inverses

Also Published As

Publication number Publication date
CA2376479A1 (fr) 2000-12-21
EP1183267A1 (fr) 2002-03-06
AU6540500A (en) 2001-01-02
JP2003502343A (ja) 2003-01-21
EP1183267A4 (fr) 2002-09-18
WO2000077033A1 (fr) 2000-12-21
IL147094A0 (en) 2002-08-14
IL190034A0 (en) 2011-08-01
IL147094A (en) 2011-04-28

Similar Documents

Publication Publication Date Title
US5700909A (en) Prosaposin and cytokine-derived peptides
JP2010150272A (ja) 環状プロサポシン由来のペプチドおよびその使用
JP2011144184A (ja) 白血病阻害因子に由来するレトロ−インベルソなペプチド
US20110190213A1 (en) Retro-inverso peptides derived from interleukin-3
US6458357B1 (en) Retro-inverso neurotrophic and analgesic peptides
US8063016B2 (en) Retro-inverso peptides derived from interleukin-6
JP2011137019A (ja) インターロイキン−３から誘導されるレトロ−インベルソペプチド
JP4786843B2 (ja) インターロイキン−６から誘導されるレトロ−インベルソペプチド
US7754690B2 (en) Method of using retro inverso peptides derived from leukemia inhibitory factor
US20020128193A1 (en) Retro-inverso prosaposin-derived peptides and use thereof
AU2010200055C1 (en) Prosaposin and cytokine-derived peptides as therapeutic agents

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100223

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100521

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110118

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110413

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110525

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110614

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110714

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140722

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees